Omeros reported $712K in Stock for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Acelrx Pharmaceuticals ACRX:US $ 1.56M 0.19M
Adamas Pharmaceuticals ADMS:US 8.68M 892K
Adma Biologics ADMA:US $ 114.12M 14.42M
Aerie Pharmaceuticals AERI:US $ 30.06M 0.65M
Alexion Pharmaceuticals ALXN:US $ 803.9M 28.2M
Alnylam Pharmaceuticals ALNY:US $ 110.95M 26.59M
Biomarin Pharmaceutical BMRN:US $ 749.41M 38.43M
Dynavax Technologies DVAX:US $ 67.3M 19.15M
Gilead Sciences GILD:US $ 2797M 191M
Heron Therapeutics HRTX:US $ 41.5M 1.3M
Knight Therapeutics Inc GUD:CN C$ 74.91M 19.13M
Omeros OMER:US $ 712K 266K
Pacira Pharmaceuticals PCRX:US $ 67.21M 1.94M
Rockwell Medical RMTI:US $ 4.03M 0.65M
United Therapeutics UTHR:US $ 96.7M 6.8M
Vertex Pharmaceuticals VRTX:US $ 333.46M 11.84M